Is Your AI Conversation Privileged?

​
May 8, 2026

‍

There are numerous AI tools available now that offer legal help, including drafting patent specifications, evaluating prior art, and preparing responses to office actions. Much has been said about the confidentiality of AI tools, you don’t want your AI tool to repeat your secrets (corporate or otherwise) to some stranger. But in the legal realm there is another concern, what if your opponent in litigation can demand access to your AI conversations.

Ordinarily, legal advice sought from a lawyer is privileged, it shouldn’t be available to an opponent in litigation. But what if you ask an AI tool for legal advice? Does using a tool that maintains privacy in the general sense protect you, or is that just as vulnerable in court?

Until recently these questions had no court-tested answer. But on the same day in February 2026, two US courts gave the first and, at first glance, opposite answers. The takeaway: an AI exchange that looks identical from the outside can be privileged in one party’s hands and discoverable in another's, depending on who set it up and how.

Heppner: When AI use sits outside the privileged relationship

In United States v. Heppner, Judge Rakoff of the Southern District of New York held that documents the defendant had generated using a public AI platform were not protected by attorney-client privilege. Bradley Heppner, anticipating a federal investigation, used a generative AI tool to draft multiple documents analyzing his potential defenses and legal exposure. He did this on his own initiative, before involving counsel, and only later shared the materials with his lawyers. Federal agents seized them in the execution of a search warrant.

The court held that no privilege attached, on three grounds. First, the AI tool was not a lawyer, and privilege requires communication with counsel. Second, the platform's terms of service permitted retention of inputs, use of those inputs to train the model, and disclosure to third parties including governmental authorities - meaning the defendant could have no reasonable expectation that what he shared would remain confidential. Third, the privilege test requires that the communication be for the purpose of obtaining legal advice. The court held that purpose was not met. No lawyer had directed Heppner to use the AI tool, so the use was not part of obtaining advice from counsel; and the platform's own terms disclaimed providing legal advice, undermining any claim that Heppner was seeking it from the tool itself.

The third point may be the most instructive. The court observed that "had counsel directed Heppner to use the AI tool, the tool might arguably be said to have functioned in a manner akin to a highly trained professional who may act as a lawyer's agent within the protection of the attorney-client privilege." This suggests the court was not hostile to AI in legal work; it was attentive to who was directing the work, in what relationship, and on what platform.

A footnote in the opinion adds a further caution. Even where information was originally privileged because it had been received from counsel, sharing it with the AI platform constituted disclosure to a third party and waived privilege as to that information. This waiver risk applies regardless of whether the user is the client or a non-lawyer team within the company.

Warner: Where work product is more forgiving

In Warner v. Gilbarco, decided the same day in the Eastern District of Michigan, a pro se plaintiff had used Chat GPT to prepare litigation materials. (A pro se plaintiff is someone who brings an action themselves without being represented by a lawyer.) The defendants moved to compel production of those materials. The court denied the motion, holding the materials were protected by the work-product doctrine.

Work product is a distinct protection from attorney-client privilege. It covers materials prepared in anticipation of litigation, and its waiver standard is meaningfully different. While disclosure of privileged information to a third party generally waives privilege, work-product waiver requires disclosure to an adversary, or in a manner that substantially increases the likelihood of adversary access. The court in Warner held that inputting materials into a generative AI platform did not meet that threshold, and was unconcerned that the platform "may have administrators somewhere in the background."

Warner therefore does not contradict Heppner. The two decisions apply different doctrines with different waiver standards, and they answer different questions. Together, they suggest that work product may survive AI use even where privilege would not, though the Heppner court's confidentiality analysis is a reminder that the platform's data terms could be vital, and the law in this area is still developing.

So should I avoid AI?

Read together, the cases suggest three considerations for whether work with AI is likely to be privileged:

1. the relationship within which the AI work was done;

2. the confidentiality policies of the platform on which it was done; and

3. the purpose for which it was done.

Where AI is used outside any attorney engagement, on a platform whose terms permit retention, training, and disclosure, and without an attorney  directing the work, Heppner shows that privilege can be lost.

On the other hand, where the use of AI addresses each of those concerns - qualified counsel using or directing AI use, on a platform configured to preserve confidentiality (e.g., no retention beyond what the engagement requires, no use of inputs for training, no third-party disclosure), for the purpose of providing legal advice, the analysis is materially different.

These are only the first cases on the topic. More will surely come, from more senior courts, and the law will develop case by case. And other countries may take different views from  the US. It would be premature to draw any firm conclusions, but already we have a useful guide.

From these two cases, the practical takeaways for patent drafting and prosecution are

i. make sure you know your (or your attorney’s) AI platform’s data terms; and

ii. AI use by registered patent attorneys  seems more likely to retain privilege than direct in-house (non-lawyer) use.

Visser AI, EIP's AI service for patent work, has been built around these considerations. The tools we use operate with zero data retention policies in place - meaning that not only is there no training on your data; the AI services do not retain your data at all.

Get in touch with Callum Docherty, or your usual EIP contact, if you’d like to learn more about Visser AI from EIP and Hybrid Intelligence. We can show you how we can improve outcomes and allow your patent budget to go further, while keeping your data secure.

The Latest Thought Leadership pieces in the Content Hub

No items found.
Stay in the Know

The Patent Strategist

Get expert insights and the top patent stories delivered straight to your inbox.

Heading
This is some text inside of a div block.
This is some text inside of a div block.

Latest Insights

Showing 0 of 100
Quantum IP Strategy: Own control Points, Not Patent Counts
14 October 2026
In quantum, the strongest portfolios will not be the biggest. Stuart Malcolm sets out six moves for owning the control points the market cannot route around, and the questions investors will ask.
#
Consulting
​
Targeted, Not Transformative: The UKIPO’s Considered Course on SEPs
13 October 2026
Andrew Sharples analyses the UKIPO's response to its SEP consultation, exploring proposed changes to FRAND dispute resolution, SEP transparency and licensing guidance, and what they mean for SEP holders and implementers.
#
Consulting
​
Chinese Companies in European Patent Litigation
30 September 2026
Chinese companies are becoming increasingly active in European patent litigation, both as defendants and as patent owners enforcing their own rights. This article examines the growing role of Europe and the Unified Patent Court (UPC) in global patent disputes, highlighting key cases involving Chinese businesses and the strategic opportunities and risks that come with operating in European markets. It is the first in a series exploring the practical implications of European patent enforcement for Chinese companies.
#
Patenting
​
How to mitigate prior art traps for follow-on pharma patents
27 August 2026
Follow-on patents are increasingly important for pharmaceutical innovators. Learn how new EMA clinical trial disclosure rules create prior art risks and discover practical strategies to protect pharmaceutical IP and maximise patent value.
#
Consulting
​
Chinese companies and the UPC: from enforcement targets to strategic users
13 August 2026
Chinese companies are playing an increasingly significant role in UPC litigation, accounting for around 38% of infringement actions in 2025. While many remain defendants, a growing number are actively using the Unified Patent Court to enforce their own patent rights across Europe. The trend highlights the UPC's rising importance for Chinese businesses operating in sectors such as telecommunications, semiconductors, medical devices and renewable energy, and signals a shift in global patent enforcement strategy.
#
Patenting
​
Evaluating the environmental impact of patent AI.
31 July 2026
AI's environmental impact is rarely out of the headlines, but how does it compare to the benefits it delivers in practice? In this article, Laurence Brown examines the energy use of AI-assisted patent drafting, comparing it with traditional drafting workflows. While measuring AI's true environmental footprint is far from straightforward, the analysis suggests that AI-assisted patent drafting may already be more energy efficient, while delivering significant productivity gains for patent professionals.
#
Patenting
​
UPC appeals after three years: Early indications on appeal success rates
15 July 2026
Three years into the UPC, appeal overturn rates sit at 56% for both substantive and preliminary injunction cases, with Kodak v Fujifilm among the rulings reshaping outcomes on appeal.
#
Litigation
​
The UPC After Three Years: From Experiment to Enforcement Forum
15 July 2026
1,282 cases filed at the UPC in three years: infringement actions have surged while revocation filings stayed flat, easing fears the Court would become a European patent graveyard.
#
Litigation
​
Podcast: Building an AI-Native Law Firm
26 June 2026
On the Technically Legal podcast, EIP partner Laurence Brown discusses how Visser AI is redesigning patent workflows, letting the firm offer fixed fees without trading away speed or quality.
#
Patenting
​
Choosing your SEP battleground: UPC, Germany or UK?
07 June 2026
Choosing the right venue for SEP litigation can significantly influence the outcome of FRAND disputes. This article compares the UPC, German and UK courts, examining their approaches to injunctions, FRAND defences, rate-setting and enforcement. It highlights the strategic advantages of each jurisdiction and explains why many SEP owners are increasingly turning to the UK and UPC as part of their European enforcement strategy.
#
Litigation
​
Synthetic Lethality & AI: IP Strategy in Oncology
26 May 2026
This article explores the resurgence of synthetic lethality in precision oncology, highlighting how AI and machine learning are accelerating the discovery of new therapeutic targets. It also examines growing clinical activity, investment, and the evolving intellectual property challenges shaping this emerging field.
#
Consulting
​
Inside the Visser AI Launch Party
20 May 2026
EIP has officially launched Visser AI®, our hybrid intelligence service for patent drafting and prosecution. Watch the launch film from our event at The Boundary in Shoreditch, and discover how our team of European and US patent attorneys — working with the Patently AI platform , delivers faster, lower-cost work at the EPO, USPTO and beyond.
#
Consulting
​
Protecting Your Startup: Five Intellectual Property Mistakes to Avoid
20 May 2026
Early‑stage startups often focus on product development and fundraising, but overlooking intellectual property (IP) can seriously damage long‑term value. This article explores five common IP mistakes startups make, with a particular focus on patents. It covers the risks of filing patents without professional advice, making public disclosures too early, failing to put enforceable contracts in place with third parties, misunderstanding what patent rights actually provide, and neglecting to develop a clear IP strategy. By highlighting these pitfalls and offering practical guidance, the article helps startups protect their innovations, strengthen their commercial position, and improve their prospects with investors.
#
Consulting
​
Technology, Patents, and Sport
13 May 2026
VAR, goal-line tech, AI 3D player avatars, wearable trackers, the technology reshaping the 2026 World Cup and elite sport rests on a patent system that makes the R&D investment behind it worth taking.
#
Patenting
​
Patents or Trade Secrets? When to Patent in Deep Tech Innovation
11 May 2026
Deep tech companies face unique IP challenges due to long development cycles, high upfront investment, and complex technologies that combine products and processes. This article explores when patents, trade secrets, or a combination of both offer the strongest protection. It explains how factors such as detectability, reverse engineering risk, disclosure to third parties, and employee mobility should shape IP strategy decisions. While patents are often best suited to externally visible or licensable technologies, trade secrets can be highly effective for internal processes and know‑how that deliver performance or cost advantages.
#
Patenting
​